PROGESTERONE FORMULATIONS HAVING A DESIRABLE PK PROFILE

This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters. In particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while sti...

Full description

Saved in:
Bibliographic Details
Main Authors Cacace, Janice, Thorsteinsson, Thorsteinn, Amadio, Julia, Bernick, Brian, IRANI, Neda, Persicaner, Peter H.R, Sancilio, Frederick
Format Patent
LanguageEnglish
Published 10.02.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters. In particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while still providing the benefits of a larger dosage amount.
Bibliography:Application Number: US202117348140